Dr. Cappello's Blog Post: An Inconvenient Truth: Implementing Solutions to Screening Dense Breasts to Avoid Winners and Losers
Choosing winners and losers by recommending to policy makers the disclosure of only extremely dense tissue to patients because of inconvenience, even when solutions abound, is woefully out of touch with the sole purpose of…
Read More »Joan Lunden joins Dr. Cappello at FDA meeting to standardized the reporting of dense tissue to patients.
It's crucial that the FDA act on the issue of breast density notification, reported Dr. Cappello to the MQSA committee. She last addressed the MQSA committee in November, 2011, and since then, no action has been taken by FDA…
Read More »Dr. Cappello's Blog Post: Breast Backwards: From One Size Fits All to Personalized Screening After My Advanced Stage Breast Cancer Diagnosis
The promise of Early Detection for me and innumerable women with dense breast tissue is a beautifully created fairy tale with a potentially 'unhappily ever after' ending as the size of the breast cancer and how far it has…
Read More »Dr. Cappello's Blog Post: Giving Thanks: An Inventory of Gratitude since my Advanced Breast Cancer Diagnosis
What outraged me was not the diagnosis, but its late-stage, in light of never missing an annual screening mammogram with its decade of promise for early detection. It’s been more than a dozen years since my diagnosis, and in…
Read More »Dr. Cappello's Blog Post: Sealing the Cracks of Breast Cancer Screening: The Connecticut Experiment
I slipped through a significant and potentially fatal crack nearly 13 years ago when I was diagnosed with advanced stage breast cancer. Following in the footsteps of my mother's yearly regimen, I never missed my annual…
Read More »